Congress introduced legislation this month allowing seriously ill patients to access select treatments their physicians would prescribe – without FDA approval. That would mark a fundamental departure from the FDA’s total control over every prescription drug in America. That stranglehold is the efficacy mandate – the FDA’s requirement to certify that drugs work before any patient can access them, a federal override of the physician-patient relationship. Six center directors, two commissioners, thousands of departures since January 2025 – yet the FDA’s fundamental problem is not its leadership….
Go to Source
Author:

